Development and validation of an immunoassay for quantification of NCAM-1 in human plasma
Journal of Pharmaceutical and Biomedical Analysis(2021)
摘要
•A ligand binding assay was developed for quantification of NCAM-1 in plasma.•Validated method met prespecified criteria in the range of 62.5–4000.0 ng/mL.•NCAM-1 assay has potential to be used as a biomarker assay.•Clinical testing of human plasma shows NCAM-1 assay is not influenced by age.
更多查看译文
关键词
NCAM-1,Biomarker,Assay development,Assay validation,Immunoassay,Ligand binding assay
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要